1 authorised product containing Recombinant varicella zoster virus surface glycoprotein e, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted). EU/1/18/1272/001-002 |
Recombinant varicella zoster virus surface glycoprotein e | GlaxoSmithKline Biologicals S.A. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.